ReviewAnnals of medicine and surgery (2012)2026
Multivitamins and cognitive health in older adults: bridging evidence, gaps, and controversies - a comprehensive narrative review.
Review in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: There is a high prevalence of vitamin deficiency in our healthy population; however, age-related cognitive decline is an emerging global health concern, especially with an aging population and rising cases of dementia. Many trials have been performed to assess the improvement in cognitive functions of people, especially those of older age, by daily multivitamin supplementation. Studies have shown that daily multivitamin intake significantly improves memory in older adults and reduces the risk of cognitive decline. Methods: A comprehensive search was conducted across PubMed, Embase, and Google Scholar databases from 2003 to 2023. Studies were included based on predefined PICO criteria, focusing on older adults with cognitive decline receiving multivitamin supplementation compared to placebo, with cognitive improvement as the outcome. Nineteen studies meeting the inclusion criteria, comprising randomized trials, reviews, cohort, and cross-sectional designs, were analyzed. Results: The findings reveal mixed outcomes. Multivitamin supplementation was associated with cognitive improvements, particularly in memory, global cognition, and attention, mainly in individuals with baseline deficiencies or mild cognitive impairment. B-complex vitamins and antioxidant-rich formulas showed the most promising effects. However, in well-nourished or healthy populations, results were often neutral. Variability in study design, supplement composition, assessment tools, and duration were key contributors to these inconsistencies. Conclusion: The use of multivitamins shows potential cognitive benefits in specific subgroups, particularly the elderly with nutritional deficiencies or early cognitive decline. However, universal cognitive enhancement cannot be concluded. Personalized, targeted supplementation guided by nutritional status may represent the future of cognitive health strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.